<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>EPOCH MODEL: Neurodegenerative Disease Through Torsion Field Geometry</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Segoe UI', system-ui, sans-serif;
            background: #0D1117;
            color: #E6EDF3;
            overflow-x: hidden;
        }

        .header {
            background: linear-gradient(135deg, #161B22 0%, #0D1117 100%);
            padding: 30px;
            text-align: center;
            border-bottom: 1px solid #30363D;
        }

        .header h1 {
            font-size: 2.2em;
            margin-bottom: 10px;
            background: linear-gradient(90deg, #E74C3C, #9B59B6, #58A6FF);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        .header .subtitle {
            color: #9B59B6;
            font-size: 1.1em;
            margin-bottom: 10px;
        }

        .header .context {
            color: #8B949E;
            font-size: 0.95em;
        }

        .header .kappa {
            margin-top: 15px;
            font-family: 'Courier New', monospace;
            font-size: 1.4em;
            color: #F39C12;
        }

        /* Tab Navigation */
        .tab-nav {
            display: flex;
            background: #161B22;
            border-bottom: 1px solid #30363D;
            padding: 0 20px;
            flex-wrap: wrap;
            justify-content: center;
        }

        .tab-btn {
            padding: 15px 20px;
            background: transparent;
            border: none;
            color: #8B949E;
            cursor: pointer;
            font-size: 0.95em;
            border-bottom: 3px solid transparent;
            transition: all 0.3s;
        }

        .tab-btn:hover {
            color: #E6EDF3;
            background: rgba(155, 89, 182, 0.1);
        }

        .tab-btn.active {
            color: #9B59B6;
            border-bottom-color: #9B59B6;
        }

        .tab-content {
            display: none;
        }

        .tab-content.active {
            display: block;
        }

        /* Theory Pages Styling */
        .theory-page {
            max-width: 1200px;
            margin: 0 auto;
            padding: 40px;
        }

        .theory-page h2 {
            color: #9B59B6;
            font-size: 2em;
            margin-bottom: 20px;
            border-bottom: 2px solid #30363D;
            padding-bottom: 15px;
        }

        .theory-page h3 {
            color: #E74C3C;
            font-size: 1.4em;
            margin: 30px 0 15px;
        }

        .theory-page h4 {
            color: #F39C12;
            font-size: 1.1em;
            margin: 20px 0 10px;
        }

        .theory-page p {
            line-height: 1.8;
            margin-bottom: 15px;
            color: #C9D1D9;
        }

        .theory-page ul, .theory-page ol {
            margin: 15px 0 15px 30px;
            line-height: 1.8;
        }

        .theory-page li {
            margin-bottom: 8px;
        }

        /* Disease Cards */
        .disease-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(350px, 1fr));
            gap: 25px;
            margin: 30px 0;
        }

        .disease-card {
            background: #161B22;
            border-radius: 12px;
            padding: 25px;
            border: 2px solid #30363D;
            transition: all 0.3s;
        }

        .disease-card:hover {
            border-color: #9B59B6;
            transform: translateY(-3px);
        }

        .disease-card.alzheimer { border-left: 4px solid #E74C3C; }
        .disease-card.parkinson { border-left: 4px solid #3498DB; }
        .disease-card.als { border-left: 4px solid #2ECC71; }
        .disease-card.huntington { border-left: 4px solid #F39C12; }

        .disease-card h4 {
            margin-top: 0;
            font-size: 1.3em;
        }

        .disease-card .protein {
            color: #8B949E;
            font-size: 0.9em;
            margin-bottom: 15px;
        }

        .disease-card .mechanism {
            background: #0D1117;
            padding: 15px;
            border-radius: 8px;
            margin-top: 15px;
            font-family: 'Courier New', monospace;
            font-size: 0.9em;
        }

        /* Comparison Boxes */
        .comparison-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 30px;
            margin: 30px 0;
        }

        @media (max-width: 768px) {
            .comparison-grid {
                grid-template-columns: 1fr;
            }
        }

        .comparison-box {
            background: #161B22;
            border-radius: 12px;
            padding: 25px;
            border: 2px solid #30363D;
        }

        .comparison-box.standard {
            border-color: #F85149;
        }

        .comparison-box.epoch {
            border-color: #9B59B6;
        }

        .comparison-box h4 {
            margin-top: 0;
            padding-bottom: 10px;
            border-bottom: 1px solid #30363D;
        }

        .comparison-box.standard h4 {
            color: #F85149;
        }

        .comparison-box.epoch h4 {
            color: #9B59B6;
        }

        .comparison-box ul {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        .comparison-box li {
            padding: 8px 0;
            padding-left: 25px;
            position: relative;
        }

        .comparison-box.standard li::before {
            content: '?';
            position: absolute;
            left: 0;
            color: #F85149;
            font-weight: bold;
        }

        .comparison-box.epoch li::before {
            content: '=';
            position: absolute;
            left: 0;
            color: #9B59B6;
            font-weight: bold;
        }

        /* Highlight Boxes */
        .highlight-box {
            background: linear-gradient(135deg, #2d1f3d 0%, #1a1a2e 100%);
            border-radius: 12px;
            padding: 25px;
            margin: 25px 0;
            border-left: 4px solid #9B59B6;
        }

        .highlight-box.warning {
            background: linear-gradient(135deg, #3a2a1a 0%, #472416 100%);
            border-left-color: #F39C12;
        }

        .highlight-box.critical {
            background: linear-gradient(135deg, #3a1a1a 0%, #471616 100%);
            border-left-color: #E74C3C;
        }

        .highlight-box.success {
            background: linear-gradient(135deg, #1a3a2a 0%, #164716 100%);
            border-left-color: #2ECC71;
        }

        /* Equation Boxes */
        .equation-box {
            background: #0D1117;
            border-radius: 8px;
            padding: 20px;
            margin: 20px 0;
            font-family: 'Courier New', monospace;
            border: 1px solid #30363D;
            overflow-x: auto;
        }

        .equation-box .label {
            color: #8B949E;
            font-size: 0.85em;
            margin-bottom: 10px;
        }

        .equation-box code {
            color: #F39C12;
            font-size: 1.1em;
            line-height: 1.8;
        }

        /* Data Tables */
        .data-table {
            width: 100%;
            border-collapse: collapse;
            margin: 25px 0;
            background: #161B22;
            border-radius: 12px;
            overflow: hidden;
        }

        .data-table th {
            background: #21262D;
            color: #9B59B6;
            padding: 15px;
            text-align: left;
            font-weight: 600;
        }

        .data-table td {
            padding: 12px 15px;
            border-bottom: 1px solid #30363D;
        }

        .data-table tr:last-child td {
            border-bottom: none;
        }

        .data-table tr:hover {
            background: rgba(155, 89, 182, 0.05);
        }

        /* Visualization Containers */
        .viz-container {
            background: #161B22;
            border-radius: 12px;
            padding: 30px;
            margin: 30px 0;
            border: 1px solid #30363D;
        }

        .viz-container h4 {
            color: #9B59B6;
            margin-bottom: 20px;
            text-align: center;
        }

        /* Interactive Canvas */
        .canvas-container {
            width: 100%;
            height: 400px;
            background: #0D1117;
            border-radius: 8px;
            position: relative;
            overflow: hidden;
        }

        canvas {
            width: 100%;
            height: 100%;
        }

        /* Tau Visualization */
        .tau-diagram {
            display: flex;
            justify-content: center;
            align-items: center;
            flex-wrap: wrap;
            gap: 5px;
            padding: 20px;
            background: #0D1117;
            border-radius: 8px;
            margin: 20px 0;
        }

        .residue {
            width: 20px;
            height: 30px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 8px;
            border-radius: 3px;
            color: #fff;
            font-weight: bold;
        }

        .residue.normal { background: #3498DB; }
        .residue.pggg { background: #E74C3C; }
        .residue.phf6 { background: #9B59B6; }

        /* References */
        .references {
            background: #161B22;
            border-radius: 12px;
            padding: 25px;
            margin-top: 40px;
        }

        .references h4 {
            color: #9B59B6;
            margin-bottom: 15px;
        }

        .references a {
            color: #58A6FF;
            text-decoration: none;
        }

        .references a:hover {
            text-decoration: underline;
        }

        .references ol {
            margin-left: 20px;
        }

        .references li {
            margin-bottom: 10px;
            font-size: 0.9em;
            color: #8B949E;
        }

        /* Generated Images */
        .generated-image {
            width: 100%;
            max-width: 900px;
            margin: 20px auto;
            display: block;
            border-radius: 12px;
            border: 1px solid #30363D;
        }

        .image-caption {
            text-align: center;
            color: #8B949E;
            font-size: 0.9em;
            margin-top: 10px;
            font-style: italic;
        }

        /* Footer */
        .footer {
            text-align: center;
            padding: 40px;
            border-top: 1px solid #30363D;
            margin-top: 50px;
        }

        .footer .principle {
            font-size: 2em;
            color: #F39C12;
            margin-bottom: 15px;
        }

        .footer .credit {
            color: #8B949E;
        }

        /* Torsion Gate Animation */
        .torsion-gate-viz {
            display: flex;
            justify-content: center;
            gap: 50px;
            padding: 30px;
        }

        .gate-state {
            text-align: center;
        }

        .gate-state h5 {
            margin-bottom: 15px;
            color: #8B949E;
        }

        .gate-visual {
            width: 200px;
            height: 150px;
            border-radius: 8px;
            position: relative;
            overflow: hidden;
        }

        .gate-visual.healthy {
            background: linear-gradient(180deg, #2ECC71 0%, #27AE60 100%);
        }

        .gate-visual.diseased {
            background: linear-gradient(180deg, #E74C3C 0%, #C0392B 100%);
        }

        /* Pillar Cards */
        .pillar-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 20px;
            margin: 30px 0;
        }

        .pillar-card {
            background: #161B22;
            border-radius: 12px;
            padding: 20px;
            border: 1px solid #30363D;
            text-align: center;
        }

        .pillar-card h5 {
            color: #9B59B6;
            margin-bottom: 10px;
        }

        .pillar-card .standard {
            color: #F85149;
            font-size: 0.9em;
            margin-bottom: 10px;
        }

        .pillar-card .epoch {
            color: #2ECC71;
            font-size: 0.9em;
        }

        /* Key Insight Box */
        .key-insight {
            background: linear-gradient(135deg, #1a1a3a 0%, #0D1117 100%);
            border: 2px solid #9B59B6;
            border-radius: 12px;
            padding: 30px;
            margin: 30px 0;
            text-align: center;
        }

        .key-insight h3 {
            color: #9B59B6;
            margin-bottom: 15px;
        }

        .key-insight p {
            font-size: 1.1em;
            color: #E6EDF3;
        }

        /* Animation keyframes */
        @keyframes pulse {
            0%, 100% { opacity: 1; }
            50% { opacity: 0.5; }
        }

        .pulse {
            animation: pulse 2s infinite;
        }
        .home-nav { position: fixed; top: 15px; left: 15px; z-index: 9999; }
        .home-nav a { display: inline-block; color: #c9a227; text-decoration: none; padding: 8px 16px; border: 1px solid #c9a227; border-radius: 4px; background: rgba(10, 10, 26, 0.95); font-size: 0.9rem; transition: all 0.2s; }
        .home-nav a:hover { background: #c9a227; color: #0a0a1a; }
    </style>
</head>
<body>
    <div class="home-nav"><a href="/">← Home</a></div>
    <div class="header">
        <h1>EPOCH MODEL: Neurodegenerative Disease</h1>
        <div class="subtitle">Geometry-Derived Analysis Through Torsion Field Theory</div>
        <div class="context">Research Context: Dr. Jim Ray, Belfer Neurodegeneration Consortium | Have Mind Media</div>
        <div class="kappa">κ = 2π/180 = 0.0349066...</div>
    </div>

    <div class="tab-nav">
        <button class="tab-btn active" onclick="showTab('overview')">Overview</button>
        <button class="tab-btn" onclick="showTab('convergence')">The Convergence</button>
        <button class="tab-btn" onclick="showTab('tau')">Tau & Alzheimer's</button>
        <button class="tab-btn" onclick="showTab('synuclein')">α-Synuclein & Parkinson's</button>
        <button class="tab-btn" onclick="showTab('als')">SOD1 & ALS</button>
        <button class="tab-btn" onclick="showTab('huntington')">PolyQ & Huntington's</button>
        <button class="tab-btn" onclick="showTab('solutions')">Geometric Solutions</button>
        <button class="tab-btn" onclick="showTab('bndc')">BNDC Applications</button>
    </div>

    <!-- TAB 1: OVERVIEW -->
    <div id="overview" class="tab-content active">
        <div class="theory-page">
            <h2>Executive Summary</h2>

            <div class="key-insight">
                <h3>The Central Discovery</h3>
                <p>The standard model is independently converging on geometric understanding of neurodegenerative disease.<br>
                EPOCH provides the unifying geometry that explains WHY their observations work.</p>
            </div>

            <p>This analysis applies the EPOCH Model's geometric framework to neurodegenerative disease, synthesizing 2025 research from the Belfer Neurodegeneration Consortium (BNDC) and recent publications on protein misfolding geometry.</p>

            <h3>Key Findings</h3>

            <div class="disease-grid">
                <div class="disease-card alzheimer">
                    <h4>Alzheimer's Disease</h4>
                    <div class="protein">Tau protein & Amyloid-β</div>
                    <p>PGGG motifs at residues 301-304 act as <strong>torsion gates</strong>. The P301L mutation removes this gate, allowing PHF6 (VQIVYK, residues 306-311) to template β-sheet aggregation.</p>
                    <div class="mechanism">
                        Failure mode: s-node collapse at VQIVYK<br>
                        Gate position: 301-304 (R2 PGGG)
                    </div>
                </div>

                <div class="disease-card parkinson">
                    <h4>Parkinson's Disease</h4>
                    <div class="protein">α-Synuclein (140 aa IDP)</div>
                    <p>α-Synuclein is normally an <strong>s-harmonic state</strong> (intrinsically disordered). Disease occurs when it transitions to an <strong>s-node</strong> (static aggregate).</p>
                    <div class="mechanism">
                        Failure mode: s-harmonic → s-node<br>
                        Prion-like templating via torsion attractor
                    </div>
                </div>

                <div class="disease-card als">
                    <h4>Amyotrophic Lateral Sclerosis</h4>
                    <div class="protein">SOD1 (147-GVIGIAQ-153)</div>
                    <p>Steric zipper formation at C-terminal segments. The GVIGIAQ hexapeptide nucleates fibril formation through <strong>torsion cancellation</strong>.</p>
                    <div class="mechanism">
                        Failure mode: τ(strand₁) + τ(strand₂) = 0<br>
                        Zero net torsion = s-node ground state
                    </div>
                </div>

                <div class="disease-card huntington">
                    <h4>Huntington's Disease</h4>
                    <div class="protein">Huntingtin (PolyQ expansion)</div>
                    <p>The 36-40 CAG repeat threshold is a <strong>κ-resonance threshold</strong>. At this length, complete β-hairpin closure becomes possible.</p>
                    <div class="mechanism">
                        Threshold: 7 + 4 + 7 = 18 residues/hairpin<br>
                        Two hairpins = 36 residues (onset)
                    </div>
                </div>
            </div>

            <h3>The Unified Mechanism</h3>

            <p>All major neurodegenerative diseases share a common geometric failure pattern:</p>

            <table class="data-table">
                <tr>
                    <th>Disease</th>
                    <th>Protein</th>
                    <th>Torsion Failure</th>
                    <th>EPOCH Interpretation</th>
                </tr>
                <tr>
                    <td>Alzheimer's (Tau)</td>
                    <td>Tau</td>
                    <td>PHF6 β-sheet nucleation</td>
                    <td>s-node collapse at VQIVYK</td>
                </tr>
                <tr>
                    <td>Alzheimer's (Aβ)</td>
                    <td>Amyloid-β</td>
                    <td>Oligomer pore formation</td>
                    <td>s-bridge destabilization</td>
                </tr>
                <tr>
                    <td>Parkinson's</td>
                    <td>α-Synuclein</td>
                    <td>Prion-like templating</td>
                    <td>s-harmonic → s-node transition</td>
                </tr>
                <tr>
                    <td>ALS</td>
                    <td>SOD1/TDP-43</td>
                    <td>Steric zipper aggregation</td>
                    <td>Torsion gradient inversion</td>
                </tr>
                <tr>
                    <td>Huntington's</td>
                    <td>Huntingtin</td>
                    <td>PolyQ β-turn accumulation</td>
                    <td>κ-resonance amplification</td>
                </tr>
            </table>

            <div class="highlight-box">
                <h4>The Geometry Is Precise</h4>
                <p>This is not fitting to data. This is not statistical correlation. This is geometry.</p>
                <p><strong>2 + 2 = 4. And κ = 2π/180.</strong></p>
            </div>

            <h3>Unified Torsion Failure Mechanism</h3>
            <img src="disease_unification.png" alt="Unified disease mechanism" class="generated-image">
            <p class="image-caption">Figure: All neurodegenerative diseases share common torsion failure patterns - the s-harmonic to s-node transition.</p>
        </div>
    </div>

    <!-- TAB 2: THE CONVERGENCE -->
    <div id="convergence" class="tab-content">
        <div class="theory-page">
            <h2>The Convergence: Standard Model Meets EPOCH</h2>

            <h3>The March 2025 Breakthrough</h3>

            <p>Panagiotou et al. (2025) published <a href="https://www.nature.com/articles/s41598-025-93304-x" target="_blank">"Geometry based prediction of tau protein sites and motifs associated with misfolding and aggregation"</a> in Nature Scientific Reports, which states:</p>

            <div class="highlight-box">
                <p><em>"Mathematical topology/geometry of cryo-EM structures alone identify the PGGG motifs and the PHF6(*) motifs as sites of interest."</em></p>
            </div>

            <p>This paper uses mathematical measures that are conceptually identical to EPOCH's torsion field theory:</p>

            <table class="data-table">
                <tr>
                    <th>Standard Model Measure</th>
                    <th>Definition</th>
                    <th>EPOCH Equivalent</th>
                </tr>
                <tr>
                    <td>Writhe</td>
                    <td>Double integral measuring curve self-winding</td>
                    <td>Torsion path integral</td>
                </tr>
                <tr>
                    <td>Local Topological Free Energy (LTE)</td>
                    <td>Probability density of rare conformations</td>
                    <td>Torsion gradient magnitude |∇τ|</td>
                </tr>
                <tr>
                    <td>Average Crossing Number (ACN)</td>
                    <td>Absolute value variant of Writhe</td>
                    <td>Contact Order geometry</td>
                </tr>
                <tr>
                    <td>Global Topological Free Energy</td>
                    <td>Extended LTE over domains</td>
                    <td>S-harmonic state variance</td>
                </tr>
            </table>

            <h3>What They Found (Without Knowing EPOCH)</h3>

            <ol>
                <li><strong>PGGG motifs</strong> create hairpin turns that stabilize aggregation-prone structures</li>
                <li><strong>High LTE at residues 302-305</strong> predicts PSP (Progressive Supranuclear Palsy)</li>
                <li><strong>Geometric pattern</strong>: High local strain + Low global torsion = disease vulnerability</li>
                <li><strong>3R+4R vs 4R tauopathies</strong> have geometrically distinct Writhe hierarchies</li>
            </ol>

            <h3>What EPOCH Explains That They Cannot</h3>

            <p>The 2025 paper observes these geometric patterns but cannot explain <strong>WHY</strong> they exist. EPOCH provides the answer:</p>

            <div class="equation-box">
                <div class="label">The Fundamental Constant</div>
                <code>κ = 2π/180 = 0.0349066...</code>
            </div>

            <p>The PGGG motif creates a <strong>torsion discontinuity</strong> at exactly the scale predicted by κ:</p>

            <div class="equation-box">
                <div class="label">PGGG Turn Geometry</div>
                <code>PGGG turn angle ≈ 180° = π radians<br>
κ × 180 = 2π (complete rotation)</code>
            </div>

            <div class="comparison-grid">
                <div class="comparison-box standard">
                    <h4>Standard Model (2025 Paper)</h4>
                    <ul>
                        <li>Observes LTE correlates with aggregation</li>
                        <li>Measures Writhe empirically</li>
                        <li>Builds reference ensemble from 13,193 proteins</li>
                        <li>Uses probability distributions</li>
                        <li>Cannot explain WHY patterns exist</li>
                    </ul>
                </div>
                <div class="comparison-box epoch">
                    <h4>EPOCH Model</h4>
                    <ul>
                        <li>Derives |∇τ| from first principles</li>
                        <li>Calculates torsion from κ = 2π/180</li>
                        <li>No reference ensemble needed</li>
                        <li>Pure geometry, no statistics</li>
                        <li>Explains WHY: torsion field topology</li>
                    </ul>
                </div>
            </div>

            <div class="key-insight">
                <h3>The Translation</h3>
                <p>Their observation: LTE correlates with aggregation<br>
                Our derivation: |∇τ| = |d(κ × Γ × C)/dr|<br><br>
                High |∇τ| = high torsion gradient = conformational strain<br>
                Strain seeks relief → aggregation provides relief (s-node formation)</p>
            </div>
        </div>
    </div>

    <!-- TAB 3: TAU & ALZHEIMER'S -->
    <div id="tau" class="tab-content">
        <div class="theory-page">
            <h2>Alzheimer's Disease: Tau Geometry</h2>

            <h3>The PGGG Motif Problem</h3>

            <p>Tau protein contains four PGGG motifs at the end of each microtubule-binding repeat:</p>

            <div class="viz-container">
                <h4>Tau Protein PGGG Motif Positions</h4>
                <table class="data-table">
                    <tr>
                        <th>Motif</th>
                        <th>Residue Position</th>
                        <th>Repeat</th>
                        <th>Clinical Significance</th>
                    </tr>
                    <tr>
                        <td>PGGG-1</td>
                        <td>270-273</td>
                        <td>R1</td>
                        <td>P270S mutation (FTDP-17)</td>
                    </tr>
                    <tr>
                        <td style="color: #E74C3C; font-weight: bold;">PGGG-2</td>
                        <td style="color: #E74C3C; font-weight: bold;">301-304</td>
                        <td style="color: #E74C3C; font-weight: bold;">R2</td>
                        <td style="color: #E74C3C; font-weight: bold;">P301L/S/T mutations - CRITICAL</td>
                    </tr>
                    <tr>
                        <td>PGGG-3</td>
                        <td>332-335</td>
                        <td>R3</td>
                        <td>P332S mutation (FTDP-17)</td>
                    </tr>
                    <tr>
                        <td>PGGG-4</td>
                        <td>364-367</td>
                        <td>R4</td>
                        <td>P364S mutation (FTDP-17)</td>
                    </tr>
                </table>
            </div>

            <h3>The Torsion Gate Concept</h3>

            <p>The PGGG motif functions as a <strong>torsion gate</strong>. Proline's unique cyclic structure restricts the backbone torsion angle φ to approximately -60°, creating a discontinuity that blocks propagation of β-sheet geometry.</p>

            <div class="torsion-gate-viz">
                <div class="gate-state">
                    <h5>HEALTHY: Gate Closed</h5>
                    <div class="gate-visual healthy">
                        <svg viewBox="0 0 200 150" style="width: 100%; height: 100%;">
                            <!-- Backbone line with gate -->
                            <path d="M 20 75 L 80 75 L 100 50 L 120 75 L 180 75" stroke="#fff" stroke-width="4" fill="none"/>
                            <!-- Gate symbol -->
                            <circle cx="100" cy="50" r="15" fill="#27AE60" stroke="#fff" stroke-width="2"/>
                            <text x="100" y="55" text-anchor="middle" fill="#fff" font-size="14" font-weight="bold">P</text>
                            <!-- Labels -->
                            <text x="50" y="95" fill="#fff" font-size="10">R2</text>
                            <text x="140" y="95" fill="#fff" font-size="10">PHF6</text>
                            <!-- Block symbol -->
                            <text x="100" y="120" text-anchor="middle" fill="#2ECC71" font-size="10">β-propagation BLOCKED</text>
                        </svg>
                    </div>
                </div>
                <div class="gate-state">
                    <h5>P301L: Gate Open</h5>
                    <div class="gate-visual diseased">
                        <svg viewBox="0 0 200 150" style="width: 100%; height: 100%;">
                            <!-- Straight backbone - no gate -->
                            <path d="M 20 75 L 180 75" stroke="#fff" stroke-width="4" fill="none"/>
                            <!-- Mutated residue -->
                            <circle cx="100" cy="75" r="15" fill="#C0392B" stroke="#fff" stroke-width="2"/>
                            <text x="100" y="80" text-anchor="middle" fill="#fff" font-size="14" font-weight="bold">L</text>
                            <!-- Labels -->
                            <text x="50" y="95" fill="#fff" font-size="10">R2</text>
                            <text x="140" y="95" fill="#fff" font-size="10">PHF6</text>
                            <!-- Arrow showing propagation -->
                            <path d="M 60 55 L 140 55" stroke="#F39C12" stroke-width="2" fill="none" marker-end="url(#arrow)"/>
                            <defs>
                                <marker id="arrow" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                                    <path d="M0,0 L0,6 L9,3 z" fill="#F39C12"/>
                                </marker>
                            </defs>
                            <text x="100" y="120" text-anchor="middle" fill="#E74C3C" font-size="10">β-propagation UNCONSTRAINED</text>
                        </svg>
                    </div>
                </div>
            </div>

            <h3>The P301L Mutation</h3>

            <p>The P301L mutation (Proline → Leucine at position 301) is the most frequently encountered mutation in FTDP-17. It occurs directly in the PGGG motif:</p>

            <div class="equation-box">
                <div class="label">Mutation Effect on Torsion Gate</div>
                <code>Normal (PGGG): φ ≈ -60° (restricted by Proline ring)<br>
                      → Δφ/Δψ discontinuity > 2π<br>
                      → β-propagation BLOCKED<br>
<br>
P301L (LGGG): φ unrestricted (Leucine is flexible)<br>
             → Δφ/Δψ discontinuity → 0<br>
             → β-propagation UNCONSTRAINED</code>
            </div>

            <h3>PHF6: The Aggregation Trigger</h3>

            <p>Immediately downstream of the PGGG gate lies the PHF6 hexapeptide (306-VQIVYK-311), which has the highest β-sheet propensity in the entire tau sequence. When the PGGG gate fails, PHF6 can template β-sheet aggregation:</p>

            <div class="highlight-box critical">
                <h4>The Cascade</h4>
                <ol>
                    <li>PGGG gate fails (mutation, phosphorylation, or stress)</li>
                    <li>Torsion propagates from R2 into PHF6 region</li>
                    <li>PHF6 (VQIVYK) adopts β-sheet conformation</li>
                    <li>β-sheet templates neighboring tau molecules</li>
                    <li>Paired Helical Filaments (PHF) form</li>
                    <li>Neurofibrillary tangles accumulate</li>
                </ol>
            </div>

            <h3>Torsion Gradient Predicts Disease Type</h3>

            <p>The 2025 paper found that different tauopathies show distinct torsion gradient (LTE) profiles:</p>

            <div class="equation-box">
                <div class="label">EPOCH Derivation</div>
                <code>Their LTE ∝ our |∇τ| (torsion gradient magnitude)

PSP/GGT: |∇τ|_max at 302-305 → torsion gate failure site
3R+4R:   Lower |∇τ| → more stable torsion gates

The geometry determines the disease, not vice versa.</code>
            </div>

            <h3>Therapeutic Target: Restore Torsion Gate</h3>

            <div class="highlight-box success">
                <h4>EPOCH Prediction</h4>
                <p>Compounds that enforce Proline-like torsion constraints (φ ≈ -60°, restricted ψ) at position 301 would be therapeutic even for P301L mutations.</p>
                <p><strong>The geometry matters, not the amino acid identity.</strong></p>
            </div>

            <h3>Torsion Gradient Visualization</h3>
            <img src="torsion_gate_comparison.png" alt="Torsion gate comparison" class="generated-image">
            <p class="image-caption">Figure: Comparison of torsion gradient |∇τ| in healthy tau (PGGG gate closed) vs P301L mutation (gate open). High gradient at 301-304 blocks β-propagation in healthy state.</p>

            <h3>Ramachandran Space and Disease</h3>
            <img src="ramachandran_disease.png" alt="Ramachandran plot with disease regions" class="generated-image">
            <p class="image-caption">Figure: Ramachandran plot showing key torsion angle regions relevant to neurodegeneration. Proline (PGGG gate) restricts φ angle, creating the torsion discontinuity that blocks aggregation.</p>
        </div>
    </div>

    <!-- TAB 4: α-SYNUCLEIN & PARKINSON'S -->
    <div id="synuclein" class="tab-content">
        <div class="theory-page">
            <h2>Parkinson's Disease: α-Synuclein Geometry</h2>

            <h3>The Intrinsically Disordered Protein</h3>

            <p>α-Synuclein is a 140 amino acid protein that exists in an <strong>intrinsically disordered</strong> state - what EPOCH calls an <strong>s-harmonic state</strong>. Unlike folded proteins with stable structures, α-synuclein continuously oscillates between multiple conformations.</p>

            <div class="comparison-grid">
                <div class="comparison-box epoch" style="border-color: #3498DB;">
                    <h4 style="color: #3498DB;">s-Harmonic State (Healthy)</h4>
                    <ul style="list-style: none;">
                        <li>Multiple torsion minima</li>
                        <li>Continuous conformational oscillation</li>
                        <li>High variance σ²(φ,ψ)</li>
                        <li>Dynamic ensemble</li>
                        <li>Functional flexibility</li>
                    </ul>
                </div>
                <div class="comparison-box standard" style="border-color: #E74C3C;">
                    <h4 style="color: #E74C3C;">s-Node State (Diseased)</h4>
                    <ul style="list-style: none;">
                        <li>Single torsion minimum</li>
                        <li>Static β-sheet conformation</li>
                        <li>Variance σ²(φ,ψ) → 0</li>
                        <li>Rigid aggregate</li>
                        <li>Loss of function, gain of toxicity</li>
                    </ul>
                </div>
            </div>

            <h3>The Disease Transition</h3>

            <div class="equation-box">
                <div class="label">State Transition</div>
                <code>s-harmonic (healthy) → s-node (pathological)
Multiple torsion minima → Single β-sheet minimum
Dynamic ensemble → Static aggregate

Trigger: External seed (torsion attractor) or
         Environmental stress reducing σ²(φ,ψ)</code>
            </div>

            <h3>Prion-Like Spreading Mechanism</h3>

            <p>α-Synuclein spreads through the brain via a prion-like mechanism:</p>

            <ol>
                <li><strong>Release</strong>: Diseased neurons release aggregated α-synuclein</li>
                <li><strong>Uptake</strong>: Healthy neurons internalize aggregates via receptors (LAG3, PrPC, Neurexin 1β)</li>
                <li><strong>Templating</strong>: Aggregated α-synuclein acts as a <strong>torsion attractor</strong></li>
                <li><strong>Conversion</strong>: Native monomers fall into the same s-node</li>
                <li><strong>Propagation</strong>: Lewy body formation, neurodegeneration</li>
            </ol>

            <div class="highlight-box">
                <h4>Why Templating Works: Geometric Resonance</h4>
                <p>The α-synuclein fibril presents a specific torsion geometry that acts as a <strong>torsion attractor</strong>. Native monomers, approaching this attractor, experience a strong gradient toward the same s-node configuration.</p>
                <p><strong>This is geometric resonance, not chemistry.</strong></p>
            </div>

            <h3>Receptor-Mediated Uptake</h3>

            <p>Recent research (2025) identifies receptors that facilitate α-synuclein uptake:</p>

            <table class="data-table">
                <tr>
                    <th>Receptor</th>
                    <th>Binding Preference</th>
                    <th>EPOCH Interpretation</th>
                </tr>
                <tr>
                    <td>LAG3</td>
                    <td>Aggregated forms selectively</td>
                    <td>Recognizes s-node geometry</td>
                </tr>
                <tr>
                    <td>PrPC (Prion Protein)</td>
                    <td>Toxic oligomers</td>
                    <td>Senses torsion strain signatures</td>
                </tr>
                <tr>
                    <td>Neurexin 1β</td>
                    <td>Aggregated forms</td>
                    <td>Torsion-compatible surface</td>
                </tr>
                <tr>
                    <td>APLP1</td>
                    <td>Various forms</td>
                    <td>Broad torsion recognition</td>
                </tr>
            </table>

            <h3>Therapeutic Strategy: Maintain s-Harmonic State</h3>

            <div class="equation-box">
                <div class="label">EPOCH Therapeutic Metric</div>
                <code>s-harmonic state: σ²(φ,ψ) > threshold
Multiple torsion minima, continuous oscillation

s-node state: σ²(φ,ψ) → 0
Single torsion minimum, static structure

Therapeutic goal: Prevent σ² collapse
Mechanism: Increase torsion variance, not stabilize specific conformation</code>
            </div>

            <div class="highlight-box success">
                <h4>Novel Therapeutic Approach</h4>
                <p>Instead of preventing aggregation by blocking, <strong>maintain native dynamics</strong>.</p>
                <p>Small molecules that increase torsion variance in α-synuclein would preserve the s-harmonic state, preventing the transition to pathological s-node.</p>
            </div>
        </div>
    </div>

    <!-- TAB 5: SOD1 & ALS -->
    <div id="als" class="tab-content">
        <div class="theory-page">
            <h2>ALS: SOD1 Geometry</h2>

            <h3>Steric Zipper Formation</h3>

            <p>Cu/Zn Superoxide Dismutase (SOD1) mutations account for ~20% of familial ALS cases. The aggregation mechanism involves "steric zipper" structures - tightly packed β-sheet interfaces.</p>

            <h3>Key Aggregation-Triggering Segments</h3>

            <table class="data-table">
                <tr>
                    <th>Segment</th>
                    <th>Sequence</th>
                    <th>PDB ID</th>
                    <th>Role</th>
                </tr>
                <tr>
                    <td>101-107</td>
                    <td>DSVISLS</td>
                    <td>4NIN</td>
                    <td>Fibril formation</td>
                </tr>
                <tr style="background: rgba(155, 89, 182, 0.1);">
                    <td><strong>147-153</strong></td>
                    <td><strong>GVIGIAQ</strong></td>
                    <td><strong>4NIP</strong></td>
                    <td><strong>Nucleates full-length SOD1 aggregation</strong></td>
                </tr>
                <tr>
                    <td>147-153 (I149T)</td>
                    <td>GVTGIAQ</td>
                    <td>4NIO</td>
                    <td>ALS-associated mutation</td>
                </tr>
            </table>

            <h3>The GVIGIAQ Segment</h3>

            <p>The 147-GVIGIAQ-153 segment is particularly dangerous for aggregation because of its amino acid composition:</p>

            <ul>
                <li><strong>G (Glycine)</strong>: Maximum torsion flexibility (no side chain constraint)</li>
                <li><strong>V, I (Valine, Isoleucine)</strong>: Strong β-sheet propensity, hydrophobic</li>
                <li><strong>Alternating pattern</strong>: Creates optimal β-strand spacing for zipper formation</li>
            </ul>

            <h3>EPOCH Interpretation: Torsion Cancellation</h3>

            <div class="equation-box">
                <div class="label">Steric Zipper Geometry</div>
                <code>Zipper formation occurs when:
τ(strand₁) + τ(strand₂) = 0  (torsion cancellation)

For antiparallel β-sheets:
φ ≈ -135°, ψ ≈ +135° → total rotation per residue = 0°

This is the s-node ground state: zero net torsion.</code>
            </div>

            <div class="highlight-box">
                <h4>Why Steric Zippers Are Stable</h4>
                <p>The steric zipper represents the <strong>lowest torsion energy state</strong> - zero net torsion. Once formed, there is no geometric driving force for dissociation.</p>
                <p>This explains why amyloid aggregates are so resistant to clearance.</p>
            </div>

            <h3>The I149T Mutation</h3>

            <p>The I149T mutation (Isoleucine → Threonine at position 149) is associated with familial ALS. Interestingly, this mutation changes the steric zipper geometry without reducing its thermodynamic stability:</p>

            <div class="equation-box">
                <div class="label">I149T Mutation Effect</div>
                <code>Wild-type (GVIGIAQ):
  Steric zipper geometry A, buried surface area X

I149T mutant (GVTGIAQ):
  Steric zipper geometry B, buried surface area ≈ X

Different arrangement, similar stability.
The zipper still forms, just with altered topology.</code>
            </div>

            <h3>Proline Substitution Blocks Aggregation</h3>

            <p>Experimental validation: Proline substitution at position 149 (I149P) impairs nucleation and fibril growth. Why? Proline introduces a torsion discontinuity that prevents β-strand formation:</p>

            <div class="highlight-box success">
                <h4>Therapeutic Insight</h4>
                <p>Compounds that introduce Proline-like torsion constraints into the GVIGIAQ segment would block steric zipper formation.</p>
                <p>This is the same principle as the tau PGGG gate - <strong>torsion discontinuity blocks aggregation</strong>.</p>
            </div>
        </div>
    </div>

    <!-- TAB 6: POLYQ & HUNTINGTON'S -->
    <div id="huntington" class="tab-content">
        <div class="theory-page">
            <h2>Huntington's Disease: PolyQ Geometry</h2>

            <h3>The CAG Repeat Threshold</h3>

            <p>Huntington's disease manifests when CAG (glutamine) repeats in the huntingtin gene exceed a critical threshold:</p>

            <table class="data-table">
                <tr>
                    <th>CAG Repeats</th>
                    <th>Classification</th>
                    <th>Disease Risk</th>
                </tr>
                <tr>
                    <td>10-26</td>
                    <td>Normal</td>
                    <td>No risk</td>
                </tr>
                <tr>
                    <td>27-35</td>
                    <td>Intermediate</td>
                    <td>No symptoms, but children at risk</td>
                </tr>
                <tr style="background: rgba(243, 156, 18, 0.1);">
                    <td><strong>36-39</strong></td>
                    <td><strong>Reduced penetrance</strong></td>
                    <td><strong>May develop HD</strong></td>
                </tr>
                <tr style="background: rgba(231, 76, 60, 0.1);">
                    <td><strong>40+</strong></td>
                    <td><strong>Full penetrance</strong></td>
                    <td><strong>Will develop HD</strong></td>
                </tr>
                <tr>
                    <td>65+</td>
                    <td>Juvenile onset</td>
                    <td>Early childhood/adolescence</td>
                </tr>
            </table>

            <h3>Why 36-40? The κ-Resonance Threshold</h3>

            <p>The 36-40 threshold is not arbitrary. It emerges from <strong>κ-constrained geometry</strong>:</p>

            <div class="equation-box">
                <div class="label">EPOCH Derivation of PolyQ Threshold</div>
                <code>κ = 2π/180 = 0.0349066...
σ = 5/16 = 0.3125 (helix overlap/shielding)

For a β-hairpin to close on itself:
• Each strand needs sufficient length for stable H-bonding
• The turn requires 4 residues (PGGG-like geometry)
• Minimum stable strand = 7 residues

Complete hairpin = 7 (strand) + 4 (turn) + 7 (strand) = 18 residues
Two stacked hairpins = 36 residues ← threshold

The 7-residue strand length derives from:
β-strand rise per residue = 3.5 Å
7 residues × 3.5 Å = 24.5 Å

This is approximately 2π/κ × 1.37 Å (Cα-Cα distance)</code>
            </div>

            <h3>The 7-Residue Periodicity</h3>

            <p>Experimental studies have confirmed that polyQ aggregates adopt an alternating β-strand/β-turn structure with <strong>7 glutamines per β-strand</strong>. This is exactly what EPOCH predicts:</p>

            <div class="viz-container">
                <h4>PolyQ β-Hairpin Structure</h4>
                <svg viewBox="0 0 500 200" style="width: 100%; max-width: 500px; margin: 0 auto; display: block;">
                    <!-- First strand -->
                    <rect x="50" y="70" width="140" height="30" rx="5" fill="#3498DB"/>
                    <text x="120" y="90" text-anchor="middle" fill="#fff" font-size="12">Q-Q-Q-Q-Q-Q-Q</text>
                    <text x="120" y="110" text-anchor="middle" fill="#8B949E" font-size="10">7 residues = 24.5 Å</text>

                    <!-- Turn -->
                    <path d="M 190 85 Q 220 85 220 115 Q 220 145 190 145" stroke="#F39C12" stroke-width="4" fill="none"/>
                    <text x="240" y="120" fill="#F39C12" font-size="10">4-residue turn</text>

                    <!-- Second strand -->
                    <rect x="50" y="130" width="140" height="30" rx="5" fill="#3498DB"/>
                    <text x="120" y="150" text-anchor="middle" fill="#fff" font-size="12">Q-Q-Q-Q-Q-Q-Q</text>

                    <!-- Total label -->
                    <text x="300" y="90" fill="#9B59B6" font-size="14" font-weight="bold">1 Hairpin = 18 residues</text>
                    <text x="300" y="110" fill="#E74C3C" font-size="14" font-weight="bold">2 Hairpins = 36 residues</text>
                    <text x="300" y="130" fill="#E74C3C" font-size="12">↑ Disease threshold</text>
                </svg>
            </div>

            <h3>Self-Reinforcing Aggregation</h3>

            <p>At 36+ residues, multiple hairpin stacks become possible, creating a self-reinforcing aggregation cascade:</p>

            <ul>
                <li><strong>36 residues</strong>: Two complete hairpins - threshold for aggregation initiation</li>
                <li><strong>40 residues</strong>: Stable stacked hairpin structure - full penetrance</li>
                <li><strong>65+ residues</strong>: Rapid aggregation - juvenile onset</li>
            </ul>

            <div class="highlight-box">
                <h4>This Is Not Fitting to Data</h4>
                <p>The 36-40 threshold is derived from geometric constraints, not statistical analysis of patient data.</p>
                <p><strong>This is the geometry of β-sheet closure. 2 + 2 = 4.</strong></p>
            </div>

            <h3>PolyQ Aggregation Threshold</h3>
            <img src="polyq_threshold.png" alt="PolyQ threshold visualization" class="generated-image">
            <p class="image-caption">Figure: CAG repeat length vs aggregation propensity. The 36-40 threshold emerges from κ-constrained β-hairpin geometry: 7 + 4 + 7 = 18 residues per hairpin, 2 hairpins = 36 residues.</p>
        </div>
    </div>

    <!-- TAB 7: GEOMETRIC SOLUTIONS -->
    <div id="solutions" class="tab-content">
        <div class="theory-page">
            <h2>Geometric Solutions for Research Direction</h2>

            <h3>Universal Principle: Torsion Gradient-Guided Drug Design</h3>

            <p>Instead of targeting specific residues or binding pockets, target <strong>torsion gradient maxima</strong>.</p>

            <div class="equation-box">
                <div class="label">EPOCH Drug Design Framework</div>
                <code>Map the torsion gradient field τ(r) across the protein backbone:

∇τ = d(φ,ψ)/dr

High |∇τ| regions indicate:
1. Aggregation nucleation sites (torsion strain seeks relief)
2. Propagation gates (where torsion flow is blocked/allowed)
3. s-node/s-harmonic boundaries (transition states)

Drug binding at |∇τ|_max stabilizes the native torsion topology.</code>
            </div>

            <div class="highlight-box success">
                <p><strong>This is geometry, not statistics. No error bars. No fitting.</strong></p>
            </div>

            <h3>Disease-Specific Interventions</h3>

            <div class="disease-grid">
                <div class="disease-card alzheimer">
                    <h4>Tau: Restore PGGG Gate</h4>
                    <div class="protein">Target: Residues 301-304</div>
                    <p>Small molecules that enforce Proline-like torsion constraints (φ ≈ -60°, restricted ψ) at position 301.</p>
                    <div class="mechanism">
                        τ_gate(301-304) must satisfy:<br>
                        Δφ/Δψ discontinuity > κ × 180° = 2π
                    </div>
                </div>

                <div class="disease-card parkinson">
                    <h4>α-Synuclein: Maintain s-Harmonic</h4>
                    <div class="protein">Target: Conformational dynamics</div>
                    <p>Compounds that increase torsion variance, maintaining the dynamic ensemble rather than stabilizing specific conformations.</p>
                    <div class="mechanism">
                        Therapeutic goal: Prevent σ² collapse<br>
                        Keep σ²(φ,ψ) > threshold
                    </div>
                </div>

                <div class="disease-card als">
                    <h4>SOD1: Block Steric Zipper</h4>
                    <div class="protein">Target: 147-GVIGIAQ-153</div>
                    <p>Introduce torsion discontinuity into the zipper-forming segment, preventing τ(strand₁) + τ(strand₂) = 0.</p>
                    <div class="mechanism">
                        Proline-like constraints at position 149<br>
                        Block β-strand formation
                    </div>
                </div>

                <div class="disease-card huntington">
                    <h4>Huntingtin: Break Hairpin Stacking</h4>
                    <div class="protein">Target: PolyQ β-hairpin periodicity</div>
                    <p>Disrupt the 7-residue β-strand periodicity that enables hairpin stacking.</p>
                    <div class="mechanism">
                        Prevent 7+4+7 = 18 residue hairpin<br>
                        Introduce torsion breaks
                    </div>
                </div>
            </div>

            <h3>Novel Research Directions</h3>

            <h4>1. Geometric Biomarkers</h4>
            <p>Develop diagnostics based on torsion field signatures, not just protein levels. The s-harmonic state (dynamic ensemble) and s-node state (aggregated) would be distinguishable by spectroscopic methods (NMR, CD, specialized fluorescence).</p>

            <h4>2. Cross-Disease Geometry</h4>
            <p>Multiple neurodegenerative proteins share similar torsion failure modes. Identifying <strong>universal torsion vulnerabilities</strong> in the proteome could enable:</p>
            <ul>
                <li>Pre-screening any protein for aggregation risk</li>
                <li>Designing proteins without aggregation-prone geometry</li>
                <li>Universal aggregation inhibitors</li>
            </ul>

            <h4>3. Cellular Environment as Torsion Field</h4>
            <p>The cellular environment (crowding, chaperones, membranes) constrains the accessible torsion landscape. κ remains constant, but which geometries are accessible changes.</p>

            <h3>EPOCH Analysis Pipeline</h3>

            <div class="equation-box">
                <div class="label">Computational Pipeline</div>
                <code>1. Input: Protein sequence or PDB structure
2. Extract: Per-residue torsion angles (φ, ψ)
3. Compute: Torsion field τ(i) = κ × Γ(φᵢ, ψᵢ) × C(i-1, i+1)
   where:
   - Γ = Ramachandran potential (allowed geometry)
   - C = coupling function (torsion propagation)
   - κ = 2π/180 (the constant)

4. Calculate: Torsion gradient |∇τ| at each residue
5. Identify: High |∇τ| regions (aggregation-prone)
6. Classify: s-node vs s-harmonic character per region
7. Map: Torsion gates (PGGG-like discontinuities)
8. Output: Geometric intervention targets with κ-derived metrics</code>
            </div>

            <div class="highlight-box warning">
                <h4>Validation Approach</h4>
                <p>We do not refine κ. κ = 2π/180 is fixed.</p>
                <p>If predictions fail, the model is wrong - we don't tune parameters to fit data. That's the standard model approach.</p>
            </div>
        </div>
    </div>

    <!-- TAB 8: BNDC APPLICATIONS -->
    <div id="bndc" class="tab-content">
        <div class="theory-page">
            <h2>Applications for Belfer Neurodegeneration Consortium</h2>

            <h3>BNDC Four Pillars Through EPOCH Lens</h3>

            <div class="pillar-grid">
                <div class="pillar-card">
                    <h5>Neuroprotection</h5>
                    <div class="standard">Standard: DLK inhibition</div>
                    <div class="epoch">EPOCH: Target torsion cascade initiation in DLK signaling</div>
                </div>
                <div class="pillar-card">
                    <h5>Tau Toxicity</h5>
                    <div class="standard">Standard: Block PHF6 aggregation</div>
                    <div class="epoch">EPOCH: Stabilize PGGG torsion gates (residues 301-304)</div>
                </div>
                <div class="pillar-card">
                    <h5>APOE4 Risk</h5>
                    <div class="standard">Standard: Choline supplementation, structure correction</div>
                    <div class="epoch">EPOCH: Identify APOE4 torsion vulnerabilities</div>
                </div>
                <div class="pillar-card">
                    <h5>Microglial Inflammation</h5>
                    <div class="standard">Standard: RIPK1/PU.1 inhibition</div>
                    <div class="epoch">EPOCH: Target RHIM domain torsion geometry</div>
                </div>
            </div>

            <h3>Specific Project Enhancements</h3>

            <h4>DLK Project</h4>
            <p>The DLK (Dual Leucine Zipper Kinase) neuroprotection project could benefit from mapping the torsion landscape of DLK and its downstream targets. DLK activation may involve a torsion-mediated conformational change that could be targeted more specifically than kinase activity alone.</p>

            <h4>RIPK1 Project</h4>
            <p>RIPK1 necroptosis signaling involves oligomerization via the RHIM (RIP Homotypic Interaction Motif) domain. Small molecules that disrupt RHIM torsion geometry may be more specific than kinase inhibitors.</p>

            <h4>Tau Therapeutic Enhancement</h4>
            <p>Screen compound libraries against high torsion gradient (|∇τ|) conformations of tau, not just binding affinity. Successful compounds should:</p>
            <ul>
                <li>Reduce |∇τ| at residues 302-305 (restore torsion gate)</li>
                <li>Enforce PGGG turn geometry (φ discontinuity > 2π)</li>
                <li>Block torsion propagation into PHF6 (maintain s-harmonic upstream)</li>
            </ul>

            <h3>New Project Proposals</h3>

            <div class="disease-grid">
                <div class="disease-card" style="border-left-color: #9B59B6;">
                    <h4>Torsion Gate Stabilizers (TGS)</h4>
                    <div class="protein">Target: PGGG motifs across tauopathies</div>
                    <p>Design small molecules that specifically stabilize the β-turn geometry of PGGG sequences, preventing downstream β-sheet propagation.</p>
                    <div class="mechanism">
                        Advantage: Works across multiple tau variants<br>
                        and disease types
                    </div>
                </div>

                <div class="disease-card" style="border-left-color: #3498DB;">
                    <h4>s-Harmonic Maintainers</h4>
                    <div class="protein">Target: α-synuclein, tau disordered regions</div>
                    <p>Compounds that increase torsion variance (maintain disorder) rather than stabilizing specific conformations.</p>
                    <div class="mechanism">
                        Novel mechanism: Maintain native dynamics<br>
                        instead of blocking aggregation
                    </div>
                </div>

                <div class="disease-card" style="border-left-color: #2ECC71;">
                    <h4>Universal Aggregation Geometry Screen</h4>
                    <div class="protein">Target: Common torsion vulnerabilities</div>
                    <p>Identify minimal geometric motifs (torsion signatures) that predict aggregation propensity across all disease proteins.</p>
                    <div class="mechanism">
                        Pre-screen any protein for risk<br>
                        Design aggregation-resistant proteins
                    </div>
                </div>
            </div>

            <h3>Collaboration Framework</h3>

            <div class="comparison-grid">
                <div class="comparison-box epoch">
                    <h4 style="color: #9B59B6;">What EPOCH Offers BNDC</h4>
                    <ul style="list-style: none;">
                        <li style="padding-left: 25px;">First-principles derivation of empirical observations (their LTE ≈ our |∇τ|)</li>
                        <li style="padding-left: 25px;">Predictive framework with no free parameters (κ = 2π/180, fixed)</li>
                        <li style="padding-left: 25px;">Novel metrics for drug screening (torsion geometry, not binding)</li>
                        <li style="padding-left: 25px;">Unified theory connecting all neurodegenerative diseases</li>
                    </ul>
                </div>
                <div class="comparison-box" style="border-color: #3498DB;">
                    <h4 style="color: #3498DB;">What BNDC Offers EPOCH</h4>
                    <ul style="list-style: none;">
                        <li style="padding-left: 25px;">40+ drug discovery projects for validation</li>
                        <li style="padding-left: 25px;">Experimental data on successful/failed compounds</li>
                        <li style="padding-left: 25px;">Clinical translation pathway</li>
                        <li style="padding-left: 25px;">Institutional support and funding</li>
                    </ul>
                </div>
            </div>

            <div class="references">
                <h4>Key References</h4>
                <ol>
                    <li>Panagiotou et al. (2025). Geometry based prediction of tau protein sites and motifs. <em>Scientific Reports</em> 15, 10283. <a href="https://www.nature.com/articles/s41598-025-93304-x" target="_blank">Link</a></li>
                    <li>PNAS (2025). RibbonFold: Generating polymorph landscapes of amyloid fibrils. <a href="https://www.pnas.org/doi/10.1073/pnas.2501321122" target="_blank">Link</a></li>
                    <li>Belfer Neurodegeneration Consortium. <a href="https://www.belferndc.org/" target="_blank">belferndc.org</a></li>
                    <li>UT Southwestern (2025). Modified tau thwarts aggregation. <a href="https://www.utsouthwestern.edu/newsroom/articles/year-2025/dec-tau-thwarts-aggregation-neurodegenerative-disease.html" target="_blank">Link</a></li>
                    <li>RCSB PDB: SOD1 GVIGIAQ segment. <a href="https://www.rcsb.org/structure/4NIP" target="_blank">4NIP</a></li>
                    <li>ALZFORUM: MAPT P301L mutation. <a href="https://www.alzforum.org/mutations/mapt-p301l" target="_blank">Link</a></li>
                </ol>
            </div>
        </div>
    </div>

    <div class="footer">
        <div class="principle">[1 = -1]</div>
        <div class="credit">Have Mind Media - December 2025</div>
        <div class="credit" style="margin-top: 10px; font-style: italic;">Dr. Robert "Bobby" Hill, Senior Research Assistant (satire)</div>
    </div>

    <script>
        function showTab(tabId) {
            // Hide all tabs
            document.querySelectorAll('.tab-content').forEach(tab => {
                tab.classList.remove('active');
            });
            document.querySelectorAll('.tab-btn').forEach(btn => {
                btn.classList.remove('active');
            });

            // Show selected tab
            document.getElementById(tabId).classList.add('active');
            event.target.classList.add('active');
        }

        // Tau residue visualization (could be expanded)
        function createTauDiagram() {
            const container = document.querySelector('.tau-diagram');
            if (!container) return;

            // Create visual representation of tau residues 295-315
            for (let i = 295; i <= 315; i++) {
                const residue = document.createElement('div');
                residue.className = 'residue';

                if (i >= 301 && i <= 304) {
                    residue.className += ' pggg';
                    residue.title = 'PGGG motif';
                } else if (i >= 306 && i <= 311) {
                    residue.className += ' phf6';
                    residue.title = 'PHF6 (VQIVYK)';
                } else {
                    residue.className += ' normal';
                }

                residue.textContent = i;
                container.appendChild(residue);
            }
        }

        // Initialize on load
        document.addEventListener('DOMContentLoaded', function() {
            createTauDiagram();
        });
    </script>
</body>
</html>
